Savient Pharmaceuticals, Inc. Bankruptcy New Filing Alert: Required Bankruptcy Report Regarding Schedules Of Assets And Liabilities, Statement Of Financial Affairs, Monthly Operating Report Or Other Periodic Report

On February 26, 2015, a required bankruptcy report regarding schedules of assets and liabilities, statement of financial affairs, monthly operating report or other periodic report was filed in the bankruptcy case of Savient Pharmaceuticals, Inc. and its affiliates.

The filing was assigned docket number 847 and is described on the court’s official docket as follows:

Post-Confirmation Report for Reporting Period October 1, 2014 Through December 31, 2014. Filed by SPI Liquidating Trust. (Attachments: # (1) Affidavit of Service) (Keane, Peter J.)

Savient Pharmaceuticals, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on October 14, 2013. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 13-12680. The bankruptcy case is currently assigned to United States Bankruptcy Judge Mary Walrath. The law firm of Skadden, Arps, Slate, Meagher & Flom LLP is acting as lead bankruptcy counsel to Savient Pharmaceuticals, Inc. in the bankruptcy case.


Leave a Reply